NASDAQ:LFMD - Nasdaq - US53216B1044 - Common Stock - Currency: USD
10.58
-0.14 (-1.31%)
The current stock price of LFMD is 10.58 USD. In the past month the price increased by 96.11%. In the past year, price increased by 34.95%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.25 | 38.99B | ||
DOCS | DOXIMITY INC-CLASS A | 38.13 | 10.09B | ||
WAY | WAYSTAR HOLDING CORP | 50.09 | 6.85B | ||
CERT | CERTARA INC | 24.04 | 1.90B | ||
SDGR | SCHRODINGER INC | N/A | 1.73B | ||
PHR | PHREESIA INC | N/A | 1.49B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 11.62 | 1.42B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.28B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
EVH | EVOLENT HEALTH INC - A | 22.68 | 1.01B | ||
HSTM | HEALTHSTREAM INC | 46.24 | 889.34M | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 844.28M |
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The firm operates through two segments: Telehealth and WorkSimpli. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. WorkSimpli is a provider of workplace and document services for consumers, gig workers, and small businesses. The company operates brands including: PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild, a provider of digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses.
LIFEMD INC
236 Fifth Avenue, Suite 400
New York City NEW YORK 10022 US
CEO: Justin Schreiber
Employees: 209
Phone: 18663515907
The current stock price of LFMD is 10.58 USD. The price decreased by -1.31% in the last trading session.
The exchange symbol of LIFEMD INC is LFMD and it is listed on the Nasdaq exchange.
LFMD stock is listed on the Nasdaq exchange.
15 analysts have analysed LFMD and the average price target is 12.24 USD. This implies a price increase of 15.69% is expected in the next year compared to the current price of 10.58. Check the LIFEMD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
LIFEMD INC (LFMD) has a market capitalization of 466.79M USD. This makes LFMD a Small Cap stock.
LIFEMD INC (LFMD) currently has 209 employees.
LIFEMD INC (LFMD) has a support level at 5.55 and a resistance level at 10.73. Check the full technical report for a detailed analysis of LFMD support and resistance levels.
The Revenue of LIFEMD INC (LFMD) is expected to grow by 31.3% in the next year. Check the estimates tab for more information on the LFMD EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
LFMD does not pay a dividend.
LIFEMD INC (LFMD) will report earnings on 2025-08-05, after the market close.
LIFEMD INC (LFMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.34).
The outstanding short interest for LIFEMD INC (LFMD) is 14.93% of its float. Check the ownership tab for more information on the LFMD short interest.
ChartMill assigns a technical rating of 9 / 10 to LFMD. When comparing the yearly performance of all stocks, LFMD is one of the better performing stocks in the market, outperforming 96.84% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to LFMD. Both the profitability and financial health of LFMD have multiple concerns.
Over the last trailing twelve months LFMD reported a non-GAAP Earnings per Share(EPS) of -0.34. The EPS increased by 54.05% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -18.79% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 81% to LFMD. The Buy consensus is the average rating of analysts ratings from 15 analysts.
For the next year, analysts expect an EPS growth of 95.09% and a revenue growth 31.3% for LFMD